Drug intelligence / Profile preview

[18F]FPEB

Development stage
Phase 1
Lead developer
Vanderbilt University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

**[18F]FPEB** is a fluorine-18-labeled radiopharmaceutical used as a PET (positron emission tomography) imaging agent to quantify and visualize **metabotropic glutamate receptor subtype 5 (mGluR5)** in the living human brain. It is a synthetic, high-affinity, negative allosteric modulator at the mGluR5 allosteric sites, with nanomolar potency (\(K_i\) in rats ~0.2 nM) and high specific activity suitable for imaging. It has been widely validated for **investigating neuropsychiatric and neurological disorders** linked to altered glutamatergic signalling, such as Parkinson's disease, major depressive disorder, addictions, schizophrenia, and autism. Safety studies indicate it is well tolerated with favorable radiation dosimetry for human PET studies[1][3][5][6].

Other names
fluorine-18 FPEBfluorine18 FPEBfluorine 18 FPEB18F-FPEB3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile
02

Targets

GRM5 (Metabotropic glutamate receptor 5)

Beyond the preview

Go deeper on [18F]FPEB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]FPEB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call